The relationship between MMP-9 promoterpolymorphism and IVF outcome

Area of Science:

• Reproductive biology
• Human genetics
• Molecular biology

Background:

• Matrix metalloproteinases (MMPs), particularly MMP9, are vital for extracellular matrix remodeling during implantation and embryo development.
• A specific single nucleotide polymorphism (SNP) in the MMP9 promoter, -1562C/T, influences gene expression.
• Understanding genetic factors influencing IVF-ET outcomes is crucial for improving fertility treatments.

Purpose of the Study:

• To investigate the association between the maternal genotype of the MMP9 -1562C/T polymorphism and the outcome of in vitro fertilization and embryo transfer (IVF-ET).

Main Methods:

• A case-control study design was employed, comparing infertile patients (n=123) with women who had a healthy child (n=147).
• Maternal DNA was analyzed for the MMP9 -1562C/T SNP using polymerase chain reaction and restriction fragment length polymorphism (PCR/RFLP).
• Statistical analysis was performed to compare genotype and allele frequencies between the case and control groups.

Main Results:

• No statistically significant differences were observed in the allele or genotype distributions of the MMP9 -1562C/T polymorphism between infertile patients and controls (P>0.05).
• Specific genotype frequencies in cases were C/C=73.17%, C/T=24.40%, T/T=2.43%, with allele frequencies C=85.36%, T=14.63%.
• Control genotype frequencies were C/C=73.46%, C/T=20.40%, T/T=6.12%, with allele frequencies C=83.67%, T=16.32%.

Conclusions:

• The MMP9 -1562C/T polymorphism does not appear to be associated with IVF-ET outcomes in the studied population.
• Further research may be needed to explore other genetic or environmental factors influencing IVF-ET success.